Scienture Holdings, Inc.

SCNX ·Healthcare, Drug Manufacturers - General, United States

Net Cash Flow Breakdown

FY2019 FY2018 FY2017 FY2015

Total Cash from Operations: $950.9K

Line Item	Value	% of Total
Other Investing	$265.3K	27.9%
Net Cash Flow	$685.6K	72.1%